by Leila Gray, University of Washington A look inside the cryo-electron microscope for molecular studies of antibodies and other biostructure research. Credit: Randy Carnell Three epidemic or pandemic coronaviruses—SARS-CoV, MERS-CoV, & SARS-CoV-2—have spilled over from animals to cause deadly illness in humans in the past 20 years. Virus researchers are determined to discover a means to broadly safeguard people...
by Mary Guiden, Colorado State University The technology being used to create SolaVAX, a coronavirus vaccine candidate, incorporates vitamin B2 or riboflavin, shown here in the lab under black light. Credit: John Eisele/CSU Photography Dr. Izabela Ragan, an assistant professor at Colorado State University, is working in her dream job. A veterinary scientist by training, she...
by University of Oxford Credit: Pixabay/CC0 Public Domain Researchers at the University of Oxford have today published in Preprints with The Lancet an analysis of further data from the ongoing trials of the vaccine. In this, they reveal that the vaccine efficacy is higher at longer prime-boost intervals, and that a single dose of the vaccine is 76%...
by Antonio Regalado archive page January 13, 2021 Moderna office in Cambridge, MassachusettsWIKIMEDIA COMMONShide Covid vaccines reprogrammed to aim at emerging new strains of the virus could reach the market quickly, without going through large clinical trials, according to officials at Moderna Therapeutics and the US government. As researchers identify mutated versions of the coronavirus that causes...
Mona Hanna-Attisha Professor of Medicine, Michigan State University Disclosure statement Mona Hanna-Attisha does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment. Sandra Lindsay, left, a nurse at Long Island Jewish Medical Center,...
